Vinod Pullarkat Selected Research

Vinod Pullarkat Research Topics

Disease

32	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 12/2012
30	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 05/2008
12	Leukemia 06/2022 - 08/2011
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 04/2005
10	Neoplasms (Cancer) 10/2020 - 05/2007
9	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 01/2003
8	Philadelphia Chromosome 01/2019 - 05/2008
6	Residual Neoplasm 02/2022 - 11/2007
6	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 02/2008
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 05/2007
4	Infections 01/2020 - 06/2008
4	Iron Overload 01/2020 - 12/2009
3	Hemorrhage 01/2021 - 03/2009
3	Hyperbilirubinemia 12/2020 - 03/2014
3	Neutropenia 01/2020 - 04/2003
3	Thrombocytopenia (Thrombopenia) 01/2020 - 03/2011
3	Venous Thromboembolism 01/2019 - 09/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2017 - 12/2009
2	Pathologic Complete Response 01/2022 - 01/2020
2	Nausea 01/2020 - 06/2008
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 07/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 10/2014
2	Cytopenia 01/2017 - 01/2003
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2016 - 08/2011
2	Systemic Mastocytosis 01/2016 - 10/2014
2	Sickle Cell Anemia (Hemoglobin S Disease) 06/2015 - 01/2014
2	Fibrosis (Cirrhosis) 11/2014 - 01/2003
2	Hyperplasia 11/2014 - 01/2014
2	Bronchiolitis Obliterans Syndrome 01/2014 - 04/2005
2	Anemia 03/2011 - 01/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2011 - 10/2005
1	Water Intoxication 10/2021
1	Hemorrhagic Cystitis 10/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Disease Progression 01/2021
1	Thrombocytosis (Thrombocythemia) 01/2021
1	Colonic Neoplasms (Colon Cancer) 10/2020
1	Febrile Neutropenia 01/2020

Drug/Important Bio-Agent (IBA)

20	venetoclaxIBA 10/2022 - 01/2018
8	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 04/2005
7	Sirolimus (Rapamycin)FDA Link 01/2022 - 02/2010
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2005
6	Azacitidine (5 Azacytidine)FDA Link 10/2022 - 01/2019
6	Inosine Triphosphate (ITP)IBA 01/2021 - 02/2008
5	blinatumomabIBA 11/2022 - 09/2017
5	Tyrosine Kinase InhibitorsIBA 02/2019 - 07/2015
5	IronIBA 06/2016 - 12/2009
4	Decitabine FDA Link 01/2021 - 01/2019
4	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 12/2012
4	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 10/2005
4	pegaspargase (Oncaspar)FDA Link 01/2019 - 03/2014
3	fludarabineIBA 01/2022 - 01/2014
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 03/2011
3	Busulfan (Busulfex)FDA Link 01/2020 - 02/2010
3	EnzymesIBA 01/2019 - 01/2013
3	Asparaginase (Elspar)FDA Link 01/2018 - 03/2014
3	AutoantibodiesIBA 01/2017 - 01/2003
3	Ferritins (Ferritin)IBA 03/2015 - 01/2010
2	Pharmaceutical PreparationsIBA 06/2022 - 03/2011
2	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2020
2	ruxolitinibIBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2008
2	Dasatinib (BMS 354825)FDA Link 11/2019 - 10/2016
2	AntioxidantsIBA 01/2019 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2014
2	romiplostim FDA Link 02/2015 - 02/2008
2	Reticulin (Reticular Fiber)IBA 11/2014 - 01/2003
2	Deferasirox FDA Link 08/2014 - 01/2013
2	Chelating AgentsIBA 08/2014 - 01/2013
2	Thrombopoietin (c-mpl Ligand)IBA 10/2012 - 01/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2006 - 04/2005
1	Chimeric Antigen ReceptorsIBA 12/2021
1	Mesna (Coenzyme M)FDA LinkGeneric 10/2021
1	AnticoagulantsIBA 01/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Transaminases (Aminotransferases)IBA 12/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2020
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 10/2020
1	Interleukin-3 (Interleukin 3)IBA 10/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2020
1	Guanosine Triphosphate (GTP)IBA 10/2020
1	Ribosomal RNAIBA 10/2020
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 10/2020
1	fms-Like Tyrosine Kinase 3IBA 07/2020

Therapy/Procedure

30	Therapeutics 10/2022 - 05/2007
26	Cell Transplantation 01/2022 - 11/2006
10	Drug Therapy (Chemotherapy) 11/2022 - 05/2007
8	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2009
5	Transplantation 01/2022 - 06/2008
5	Salvage Therapy 01/2021 - 04/2005
3	Homologous Transplantation 01/2022 - 12/2017
3	Stem Cell Transplantation 12/2017 - 10/2005
2	Lymphatic Irradiation 01/2022 - 04/2017
1	Immunotherapy 12/2021
1	Aftercare (After-Treatment) 01/2020
1	MDC protocol 01/2020